ID   NOX1_RAT                Reviewed;         563 AA.
AC   Q9WV87;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   02-OCT-2024, entry version 133.
DE   RecName: Full=NADPH oxidase 1;
DE            Short=NOX-1;
DE            EC=1.6.3.- {ECO:0000269|PubMed:10485709, ECO:0000269|PubMed:25228390};
DE   AltName: Full=Mitogenic oxidase 1;
DE            Short=MOX-1;
DE   AltName: Full=NADH/NADPH mitogenic oxidase subunit P65-MOX;
DE   AltName: Full=NOH-1;
GN   Name=Nox1; Synonyms=Mox1, Noh1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Colon epithelium;
RX   PubMed=10485709; DOI=10.1038/43459;
RA   Suh Y.-A., Arnold R.S., Lassegue B., Shi J., Xu X., Sorescu D., Chung A.B.,
RA   Griendling K.K., Lambeth J.D.;
RT   "Cell transformation by the superoxide-generating oxidase Mox1.";
RL   Nature 401:79-82(1999).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH NOXA1, PHOSPHORYLATION AT
RP   THR-429, AND MUTAGENESIS OF THR-89 AND THR-429.
RX   PubMed=25228390; DOI=10.1161/circresaha.115.304267;
RA   Streeter J., Schickling B.M., Jiang S., Stanic B., Thiel W.H., Gakhar L.,
RA   Houtman J.C., Miller F.J. Jr.;
RT   "Phosphorylation of Nox1 regulates association with NoxA1 activation
RT   domain.";
RL   Circ. Res. 115:911-918(2014).
CC   -!- FUNCTION: NADPH oxidase that catalyzes the generation of superoxide
CC       from molecular oxygen utilizing NADPH as an electron donor.
CC       {ECO:0000269|PubMed:10485709, ECO:0000269|PubMed:25228390}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADPH + 2 O2 = H(+) + NADP(+) + 2 superoxide;
CC         Xref=Rhea:RHEA:63180, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:18421, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         Evidence={ECO:0000269|PubMed:10485709, ECO:0000269|PubMed:25228390};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000305};
CC   -!- ACTIVITY REGULATION: The oxidase activity is potentiated by NOXA1 and
CC       NOXO1. {ECO:0000250|UniProtKB:Q9Y5S8}.
CC   -!- SUBUNIT: NOX1, NOXA1, NOXO1, RAC1 and CYBA forms a functional
CC       multimeric complex supporting ROS production. Interacts with NOXO1.
CC       Interacts (via FAD-binding FR-type domain) with ARHGEF7 (via PH domain)
CC       (By similarity). The phosphorylated form at Thr-429 interacts with
CC       NOXA1 with greater affinity (PubMed:25228390).
CC       {ECO:0000250|UniProtKB:Q9Y5S8, ECO:0000269|PubMed:25228390}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, invadopodium membrane
CC       {ECO:0000250|UniProtKB:Q9Y5S8}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell membrane {ECO:0000250|UniProtKB:Q9Y5S8}; Multi-pass
CC       membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in vascular smooth muscle cells.
CC       {ECO:0000269|PubMed:10485709}.
CC   -!- PTM: Phosphorylation at Thr-429 mediated by PKC/PRKBC positively
CC       regulates its interaction with NOXA1 and enzyme activity.
CC       {ECO:0000269|PubMed:25228390}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF152963; AAD39542.1; -; mRNA.
DR   RefSeq; NP_446135.1; NM_053683.1.
DR   AlphaFoldDB; Q9WV87; -.
DR   SMR; Q9WV87; -.
DR   STRING; 10116.ENSRNOP00000065995; -.
DR   ChEMBL; CHEMBL1075231; -.
DR   PeroxiBase; 5408; RnoNOx01.
DR   GlyCosmos; Q9WV87; 2 sites, No reported glycans.
DR   GlyGen; Q9WV87; 2 sites.
DR   iPTMnet; Q9WV87; -.
DR   PhosphoSitePlus; Q9WV87; -.
DR   PaxDb; 10116-ENSRNOP00000065995; -.
DR   GeneID; 114243; -.
DR   KEGG; rno:114243; -.
DR   AGR; RGD:620598; -.
DR   CTD; 27035; -.
DR   RGD; 620598; Nox1.
DR   eggNOG; KOG0039; Eukaryota.
DR   InParanoid; Q9WV87; -.
DR   OrthoDB; 367877at2759; -.
DR   PhylomeDB; Q9WV87; -.
DR   Reactome; R-RNO-5668599; RHO GTPases Activate NADPH Oxidases.
DR   Reactome; R-RNO-9013149; RAC1 GTPase cycle.
DR   PRO; PR:Q9WV87; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0042995; C:cell projection; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005769; C:early endosome; ISO:RGD.
DR   GO; GO:0005768; C:endosome; ISO:RGD.
DR   GO; GO:0043020; C:NADPH oxidase complex; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016174; F:NAD(P)H oxidase H2O2-forming activity; IMP:CACAO.
DR   GO; GO:0031267; F:small GTPase binding; ISO:RGD.
DR   GO; GO:0016175; F:superoxide-generating NAD(P)H oxidase activity; IDA:UniProtKB.
DR   GO; GO:0106292; F:superoxide-generating NADPH oxidase activity; IEA:RHEA.
DR   GO; GO:0001525; P:angiogenesis; ISO:RGD.
DR   GO; GO:0060326; P:cell chemotaxis; IMP:RGD.
DR   GO; GO:0016477; P:cell migration; ISO:RGD.
DR   GO; GO:1904385; P:cellular response to angiotensin; IEP:RGD.
DR   GO; GO:0071455; P:cellular response to hyperoxia; ISO:RGD.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:RGD.
DR   GO; GO:0071288; P:cellular response to mercury ion; IEP:RGD.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IEP:RGD.
DR   GO; GO:0006952; P:defense response; IBA:GO_Central.
DR   GO; GO:0030198; P:extracellular matrix organization; ISO:RGD.
DR   GO; GO:0006749; P:glutathione metabolic process; IMP:RGD.
DR   GO; GO:0042743; P:hydrogen peroxide metabolic process; ISO:RGD.
DR   GO; GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; ISO:RGD.
DR   GO; GO:0007254; P:JNK cascade; ISO:RGD.
DR   GO; GO:0000165; P:MAPK cascade; ISO:RGD.
DR   GO; GO:0014043; P:negative regulation of neuron maturation; IMP:RGD.
DR   GO; GO:0072592; P:oxygen metabolic process; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0090261; P:positive regulation of inclusion body assembly; IMP:RGD.
DR   GO; GO:0045726; P:positive regulation of integrin biosynthetic process; ISO:RGD.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IMP:RGD.
DR   GO; GO:1902177; P:positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IMP:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0032930; P:positive regulation of superoxide anion generation; IMP:RGD.
DR   GO; GO:1904754; P:positive regulation of vascular associated smooth muscle cell migration; IMP:RGD.
DR   GO; GO:1904707; P:positive regulation of vascular associated smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0010575; P:positive regulation of vascular endothelial growth factor production; ISO:RGD.
DR   GO; GO:0003081; P:regulation of systemic arterial blood pressure by renin-angiotensin; ISO:RGD.
DR   GO; GO:0000302; P:response to reactive oxygen species; IDA:RGD.
DR   GO; GO:0042554; P:superoxide anion generation; IMP:BHF-UCL.
DR   CDD; cd06186; NOX_Duox_like_FAD_NADP; 1.
DR   Gene3D; 3.40.50.80; Nucleotide-binding domain of ferredoxin-NADP reductase (FNR) module; 1.
DR   Gene3D; 2.40.30.10; Translation factors; 1.
DR   InterPro; IPR000778; Cyt_b245_heavy_chain.
DR   InterPro; IPR013112; FAD-bd_8.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR013130; Fe3_Rdtase_TM_dom.
DR   InterPro; IPR013121; Fe_red_NAD-bd_6.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR050369; RBOH/FRE.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   PANTHER; PTHR11972; NADPH OXIDASE; 1.
DR   PANTHER; PTHR11972:SF71; NADPH OXIDASE 1; 1.
DR   Pfam; PF08022; FAD_binding_8; 1.
DR   Pfam; PF01794; Ferric_reduct; 1.
DR   Pfam; PF08030; NAD_binding_6; 1.
DR   PRINTS; PR00466; GP91PHOX.
DR   SFLD; SFLDS00052; Ferric_Reductase_Domain; 1.
DR   SFLD; SFLDG01168; Ferric_reductase_subgroup_(FRE; 1.
DR   SUPFAM; SSF52343; Ferredoxin reductase-like, C-terminal NADP-linked domain; 1.
DR   SUPFAM; SSF63380; Riboflavin synthase domain-like; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Cell projection; Electron transport; FAD;
KW   Flavoprotein; Glycoprotein; Heme; Iron; Membrane; Metal-binding; NADP;
KW   Oxidoreductase; Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..563
FT                   /note="NADPH oxidase 1"
FT                   /id="PRO_0000210149"
FT   TOPO_DOM        1..8
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        9..31
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        32..44
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        45..69
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        70..102
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        103..123
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        124..167
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        168..188
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        189..206
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        207..227
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        228..395
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        396..416
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        417..563
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          54..282
FT                   /note="Ferric oxidoreductase"
FT   DOMAIN          283..390
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT   REGION          396..535
FT                   /note="Interaction with NOXO1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y5S8"
FT   BINDING         101
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000305"
FT   BINDING         115
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000305"
FT   BINDING         208
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000305"
FT   BINDING         220
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000305"
FT   BINDING         337..343
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         429
FT                   /note="Phosphothreonine; by PKC/PRKCB"
FT                   /evidence="ECO:0000269|PubMed:25228390"
FT   CARBOHYD        161
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        241
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         89
FT                   /note="T->A: No effect on catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:25228390"
FT   MUTAGEN         429
FT                   /note="T->A: Loss of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:25228390"
SQ   SEQUENCE   563 AA;  65177 MW;  2B74BCA021CC3335 CRC64;
     MGNWLVNHWL SVLFLVSWLG LNIFLFVYVF LNYEKSDKYY YTREILGTAL ALARASALCL
     NFNSMVILIP VCRNLLSFLR GTCSFCNHTL RKPLDHNLTF HKLVAYMICI FTAIHIIAHL
     FNFERYSRSQ QAMDGSLASV LSSLFHPEKE DSWLNPIQSP NVTVMYAAFT SIAGLTGVVA
     TVALVLMVTS AMEFIRRNYF ELFWYTHHLF IIYIICLGIH GLGGIVRGQT EESMSESHPR
     NCSYSFHEWD KYERSCRSPH FVGQPPESWK WILAPIAFYI FERILRFYRS RQKVVITKVV
     MHPCKVLELQ MRKRGFTMGI GQYIFVNCPS ISFLEWHPFT LTSAPEEEFF SIHIRAAGDW
     TENLIRTFEQ QHSPMPRIEV DGPFGTVSED VFQYEVAVLV GAGIGVTPFA SFLKSIWYKF
     QRAHNKLKTQ KIYFYWICRE TGAFAWFNNL LNSLEQEMDE LGKPDFLNYR LFLTGWDSNI
     AGHAALNFDR ATDVLTGLKQ KTSFGRPMWD NEFSRIATAH PKSVVGVFLC GPPTLAKSLR
     KCCRRYSSLD PRKVQFYFNK ETF
//
